Autophagy Induction After Bortezomib for Myeloma
Clinical trial NCT01594242 · COMPLETED
Trial details
- NCT number
- NCT01594242
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-10
- Primary completion
- 2015-03-02
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.